NATIONAL HEALTH INVESTORS INC Amended Insider Trading Activity

PASCOE KEVIN CARLTON reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 03/30/2026 - 11:28 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

PASCOE KEVIN CARLTON reported acquisition or exercise transactions in this Form 4 filing.

National Health Investors Inc. reported that Chief Investment Officer Kevin Carlton Pascoe received a grant of 4,726 shares of common stock on March 3, 2026, at no cash cost to him. After this compensation-related award, he directly holds 73,082 common shares.

The filing is an amended Form 4 that corrects an earlier administrative error, which had overstated the number of shares awarded on that date by 346 shares. This amendment updates the record to show the accurate number of shares granted.

Insider Trade Summary

Grant/Award: 4,726 shares

Grant/Award 1 txn

Insider PASCOE KEVIN CARLTON

Role Chief Investment Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,726	$0.00	$0.00

Holdings After Transaction: Common Stock — 73,082 shares (Direct)

Holdings Before and After: Common Stock, 68,356 to 73,082 shares (Direct)

Footnotes (1)

1. F1. Due to an administrative error, the number of securities reported as awarded to the Reporting Person on March 3, 2026 was overstated by 346 shares. This Form 4/A is being filed to report the correct number of securities awarded.

Key Figures

Shares granted: 4,726 shares Price per share for award: $0.0000 per share Shares held after transaction: 73,082 shares +1 more

4 metrics

Shares granted 4,726 shares Common stock award on March 3, 2026

Price per share for award $0.0000 per share Indicates compensation grant, not market purchase

Shares held after transaction 73,082 shares Direct ownership following March 3, 2026 grant

Prior overstatement amount 346 shares Earlier award count overstated by this amount

Key Terms

Form 4/A, administrative error, Grant, award, or other acquisition, Chief Investment Officer

4 terms

Form 4/A regulatory

"This Form 4/A is being filed to report the correct number"

Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.

administrative error other

"Due to an administrative error, the number of securities reported"

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Chief Investment Officer financial

"officer_title": "Chief Investment Officer""

A chief investment officer (CIO) is the person responsible for managing a company or organization’s investments and financial strategies. They make key decisions about where to put money to help grow wealth or achieve financial goals, much like a coach plans a team’s game strategy. Their work matters to investors because it influences how effectively an organization’s assets are used to generate returns.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NHI Chief Investment Officer Kevin Pascoe report?

Kevin Pascoe reported receiving a grant of 4,726 shares of National Health Investors common stock. The shares were awarded as compensation, not purchased in the market, and increased his direct holdings to 73,082 shares after the transaction.

Why did National Health Investors (NHI) file an amended Form 4/A?

The amended Form 4/A corrects an earlier administrative error in the reported award to Kevin Pascoe. The prior filing overstated the number of shares granted by 346, and this amendment updates the record to reflect the accurate 4,726-share grant.

How many NHI shares does Kevin Pascoe hold after the corrected award?

After the corrected grant of 4,726 shares, Kevin Pascoe directly holds 73,082 shares of National Health Investors common stock. This figure reflects his total direct ownership immediately following the March 3, 2026 compensation award.

Was cash paid for the NHI shares granted to Kevin Pascoe?

No cash was paid for the 4,726 shares granted to Kevin Pascoe. The filing shows a price per share of 0.0000, indicating a stock award given as compensation rather than a market purchase or sale transaction.

Does this NHI Form 4/A indicate any stock sales by Kevin Pascoe?

The Form 4/A does not report any stock sales by Kevin Pascoe. It shows only an acquisition of 4,726 common shares through a grant or award, with no sell transactions or derivative exercises disclosed in the provided data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PASCOE KEVIN CARLTON

(Last) (First) (Middle)

222 ROBERT ROSE DRIVE

(Street)

MURFREESBORO TENNESSEE 37129

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Investment Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
03/05/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		A		4,726(1)	A	$0	73,082	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Due to an administrative error, the number of securities reported as awarded to the Reporting Person on March 3, 2026 was overstated by 346 shares. This Form 4/A is being filed to report the correct number of securities awarded.

	/s/ Kimberly V. Ouimet, by limited power of attorney	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)